We have a lot of model data relevant to the Illuminating the druggable genome project.
See: The human genome and drug discovery after a decade. Roads (still) not taken
http://arxiv.org/abs/1102.0448
and the program website: http://www.ncats.nih.gov/idg
We had a preliminary analysis of these genes, attached.
Drug and phenotype annotation coverage in Monarch for genes in each of the four druggable gene families. Only ~25% of genes have known drug targets (+drug), nearly all of which also have phenotype annotations in human (H) or model (M) organisms. Phenotypes alone add value for comparative analysis, approaching up to 90% coverage for these gene families. Human phenotypes are from OMIM and GWAS; models span mouse, rat, fish, fly, and worm orthologs. (n=#genes per class.)
We have a lot of model data relevant to the Illuminating the druggable genome project. See: The human genome and drug discovery after a decade. Roads (still) not taken http://arxiv.org/abs/1102.0448 and the program website: http://www.ncats.nih.gov/idg
We had a preliminary analysis of these genes, attached. Drug and phenotype annotation coverage in Monarch for genes in each of the four druggable gene families. Only ~25% of genes have known drug targets (+drug), nearly all of which also have phenotype annotations in human (H) or model (M) organisms. Phenotypes alone add value for comparative analysis, approaching up to 90% coverage for these gene families. Human phenotypes are from OMIM and GWAS; models span mouse, rat, fish, fly, and worm orthologs. (n=#genes per class.)
@cmungall